and the potential of a cure by gene editing and replicating generic donor T-cells seems to have ramifications for CLL. The company Cellectis suggests that this is true, see cellectis.com/en/content/uc... The edited T-cells attack lymphocytes that display the CD19 protein and the second edit to their genetic profile stops them attacking the host.
I don't know the full story. Do we have some more information on the treatment of baby Layla? What other drugs was she receiving? What is the relevance to CLL?
Written by
nigeldodd
To view profiles and participate in discussions please or .
Here are previous post with comments... the great step forward is that this is an off the shelf technology, which will hopefully lower the astronomical costs of this treatment... which is currently custom made for each patient.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.